Disease | hepatitis c |
Symptom | C0019204|hepatocellular carcinoma |
Sentences | 121 |
PubMedID- 25654412 | Materials and methods: all patients who had undergone transplant for hepatocellular carcinoma associated with hepatitis c virus from 2002 to 2012 were evaluated retrospectively. |
PubMedID- 19879972 | Background & aims: the effects of antiviral therapy on prevention of hepatocellular carcinoma (hcc) in patients with hepatitis c virus (hcv)-related cirrhosis are unclear. |
PubMedID- 23463401 | hepatocellular carcinoma in patients with chronic hepatitis c virus infection in the asia-pacific region. |
PubMedID- 25667487 | Patients and methods: serum samples were collected preoperatively from 125 patients with hepatocellular carcinoma associated with hepatitis c virus infection who underwent curative hepatectomy. |
PubMedID- 22875473 | Background: we investigated whether the administration of maintenance doses of interferon prevented hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
PubMedID- 24462733 | A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis c and cirrhosis. |
PubMedID- 25657603 | In a recent report from our institution, we identified over a three-year period 3% (9/298) of ltx patients who developed severe hf after ltx.62 in these nine patients, etiology of liver failure was hepatitis c with hepatocellular carcinoma in four, hemochromatosis in four (with one showing evidence of iron deposition in the heart on biopsy), and one with primary biliary cirrhosis. |
PubMedID- 22096937 | Antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis c virus-related chronic hepatitis and cirrhosis. |
PubMedID- 21253791 | Several noncurative treatments also appear to reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c. |
PubMedID- 24703510 | Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis c virus infection. |
PubMedID- 23426277 | Association of interleukin-28b genotype and hepatocellular carcinoma recurrence in patients with chronic hepatitis c. |
PubMedID- 23497542 | In japan, chronic hepatitis c is associated with 90% of hepatocellular carcinoma (hcc) cases, and hcc is associated with liver cirrhosis in 85% of all cases. |
PubMedID- 25650331 | Purpose: to evaluate whether a hepatic fibrosis index (hfi), quantified on the basis of hepatic contour abnormality, is a risk factor for the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
PubMedID- 25788045 | Methods: serum ferritin was measured in 487 chronic hepatitis c patients without history of hepatocellular carcinoma (hcc) after excluding patients in phlebotomy, those with overt chronic gastrointestinal bleeding and those who achieved sustained virological response before enrollment. |
PubMedID- 21520203 | Occult hepatitis b virus infection and hepatocellular carcinoma development in patients with chronic hepatitis c. |
PubMedID- 25743000 | Objective: to determine the impact of phlebotomy on the laboratory values and the incidence of hepatocellular carcinoma (hcc) in patients with hepatitis c. |
PubMedID- 26017875 | Alterations of wnt/beta-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis c virus. |
PubMedID- 23065464 | Data on the safety and efficacy of combination therapy in chronic hepatitis c patients with hepatocellular carcinoma (hcc) is scarce and even more so in hiv/hcv co-infected subjects. |
PubMedID- 21766498 | Purpose: the aim of this study was to compare patients with hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection with patients with liver cirrhosis associated with hcv virus infection. |
PubMedID- 20458764 | Aim: to elucidate the role of insulin resistance (ir) and serum adiponectin level in hepatocellular carcinoma (hcc) associated with chronic hepatitis c. |
PubMedID- 25559606 | The effect of hiv viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis c and hiv coinfection. |
PubMedID- 22004425 | Genetic risk of hepatocellular carcinoma in patients with hepatitis c virus: a case control study. |
PubMedID- 24662676 | Given the role of hepatocellular cd81 in hcv infection and the association of chronic hepatitis c with hepatocellular carcinoma (hcc) there is a growing interest in studying the function of cd81 in hepatocytes. |
PubMedID- 22212964 | Viral hepatitis among somali immigrants in minnesota: association of hepatitis c with hepatocellular carcinoma. |
PubMedID- 23122451 | Is serum level of methylated rassf1a valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis c. |
PubMedID- 21133598 | Comparison of serum survivin and alpha fetoprotein in egyptian patients with hepatocellular carcinoma associated with hepatitis c viral infection. |
PubMedID- 21278701 | Conclusions: the incidence of hepatocellular carcinoma associated with hepatitis c infection decreased after 2001 in kyushu area. |
PubMedID- 24843320 | Previous reports have shown that interferon (ifn)-based therapy decreases the risk of development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c virus (hcv) infection. |
PubMedID- 21331763 | Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis c. |
PubMedID- 21170963 | Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc). |
PubMedID- 22410057 | The primary liver diseases included hepatitis b virus (n=2), alcoholic liver cirrhosis (n=2), cryptogenic liver disease (n=1), and hepatitis c virus with hepatocellular carcinoma (n=1). |
PubMedID- 26394142 | End-stage liver disease and hepatocellular carcinoma due to hepatitis c virus (hcv) infection constitute one of the main indications for liver transplantation (lt) worldwide 1. |
PubMedID- 21056500 | Background & aims: evidence on the efficacy of antiviral treatment in chronic hepatitis c (chc) patients with hepatocellular carcinoma (hcc) after curative treatment is scarce. |
PubMedID- 21461077 | Background/aims: despite great progress, antiviral treatment for chronic hepatitis c in patients with prior hepatocellular carcinoma (hcc) has been rarely investigated. |
PubMedID- 26191473 | In addition, dm has been suggested to enhance the development of hepatocellular carcinoma in patients with chronic hepatitis c (kawamura et al. |
PubMedID- 24393884 | Case 1 involved a 63-year-old woman who had multiple hepatocellular carcinomas (hcc) associated with hepatitis c virus infection. |
PubMedID- 21129375 | Background & aims: interferon reportedly decreases the incidence of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |
PubMedID- 22207106 | Randomized controlled trials also confirm that glycyrrhizin and its derivatives can improve the hepatocellular injury in chronic hepatitis b or c patients, and reduce the risk for hepatocellular carcinoma in patients with hepatitis c virus-induced cirrhosis . |
PubMedID- 23509319 | Statins and the risk of hepatocellular carcinoma in patients with hepatitis c virus infection. |
PubMedID- 25912838 | We assessed the effects of hvpg and svr on the risk of liver decompensation, hepatocellular carcinoma, and/or death in patients with hepatitis c-related cirrhosis. |
PubMedID- 20981260 | A 73-year-old man with a history of hepatocellular carcinoma associated with hepatitis c virus-related cirrhosis was referred to the department of urology because a thickened wall of the urinary bladder was incidentally detected by computed tomography (ct). |
PubMedID- 20883676 | Background: there are few blood tests for an efficient detection of hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection. |
PubMedID- 26301052 | hepatitis c infection can lead to cirrhosis and hepatocellular carcinoma and it is an important cause of mortality and morbidity. |
PubMedID- 21610221 | Background: this study explores the influence of two functional genetic polymorphisms in the regulated on activation in normal t-cell expressed and secreted(rantes) promoter on the risk of hepatocellular carcinoma (hcc) occurrence in patients with alcoholic or hepatitis c virus (hcv)-related cirrhosis. |
PubMedID- 23849467 | The present cross-sectional study investigated 12 perfluoroalkyl substances (pfass) in serum (n=79) and liver (n=66) samples from patients who had undergone liver transplantation for a range of conditions, such as hepatocellular carcinoma (hcc), cirrhosis due to chronic hepatitis c viral infection (hcv), both hcc and hcv, amyloidosis or acute liver failure. |
PubMedID- 22588449 | Skull metastasis from hepatocellular carcinoma with hepatitis c. |
PubMedID- 20404016 | The incidence of hepatocellular carcinoma is rising due to alcohol drinking, hepatitis c viral infection and metabolic syndrome. |
PubMedID- 21718500 | Reported a correlation between a diabetic pattern of the 75 g oral glucose tolerance test ogtt and hepatocarcinogenesis and considered it a significant risk factor for hepatocellular carcinoma (hcc) in patients with hepatitis c virus . |
PubMedID- 23657093 | Untreated chronic hepatitis c can lead to cirrhosis, hepatocellular carcinoma and death 2. |
PubMedID- 21931376 | Objectives: prospective studies of serum hepatocellular carcinoma (hcc) biomarkers in patients with advanced hepatitis c are lacking. |